In a report released today, Michael Matson from Needham reiterated a Buy rating on Boston Scientific (BSX – Research Report), with a price target of $48.00. The company's shares closed last Wednesday at $36.28, close to its 52-week low of $35.09. According to TipRanks.com, Matson is a 3-star analyst with an average return of 1.1% and a 43.9% success rate. Matson covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Cardiovascular Systems, and Zimmer Biomet Holdings. Currently, the analyst consensus on Boston Scientific is a Strong Buy with an average price target of $49.67.
https://www.tipranks.com/news/blurbs/needham-thinks-boston-scientifics-stock-is-going-to-recover?utm_source=advfn.com&utm_medium=referral
Boston Scientific (NYSE:BSX)
Historical Stock Chart
From Sep 2022 to Oct 2022 Click Here for more Boston Scientific Charts.
Boston Scientific (NYSE:BSX)
Historical Stock Chart
From Oct 2021 to Oct 2022 Click Here for more Boston Scientific Charts.